1,1-dimethylheptyl-11-hydroxytetrahydrocannabinol has been researched along with arachidonylcyclopropylamide in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Buzard, DJ; Han, S; Jones, RM; Thatte, J | 1 |
| Hsu, TH; Lin, YJ; Ruan, T; Yeh, CM | 1 |
1 review(s) available for 1,1-dimethylheptyl-11-hydroxytetrahydrocannabinol and arachidonylcyclopropylamide
| Article | Year |
|---|---|
Therapeutic utility of cannabinoid receptor type 2 (CB(2)) selective agonists.
Topics: Animals; Drug Design; Humans; Ligands; Models, Molecular; Molecular Conformation; Receptor, Cannabinoid, CB2; Structure-Activity Relationship; Substrate Specificity | 2013 |
1 other study(ies) available for 1,1-dimethylheptyl-11-hydroxytetrahydrocannabinol and arachidonylcyclopropylamide
| Article | Year |
|---|---|
Activation of cannabinoid CB1 receptors suppresses the ROS-induced hypersensitivity of rat vagal lung C-fiber afferents.
Topics: Acetanilides; Animals; Arachidonic Acids; Calcium Channels; Capsaicin; Dronabinol; Hydrogen Peroxide; Male; Nerve Fibers, Unmyelinated; Nerve Tissue Proteins; Purines; Rats; Rats, Sprague-Dawley; Reactive Oxygen Species; Receptor, Cannabinoid, CB1; Receptor, Cannabinoid, CB2; Receptors, Purinergic P2X; Respiratory Hypersensitivity; Transient Receptor Potential Channels; TRPA1 Cation Channel; Vagus Nerve | 2016 |